Startup compensation is often an opaque and awkward topic for first-time academic founders. How much equity do I receive? My CEO? The PI(s)? Other co-founders? How will my choices affect future compensation?
Therapeutics remain the primary focus for life science venture investments. As we all know, pre-clinical development of therapeutics is complicated, time consuming, and capital intensive. In the early stages of development, multiple aspects of a therapeutic product need to be optimized to enhance its drug-like properties. However, given the limited time and resources in the academic setting, what aspects of development should inventors focus on? Before diving into drug development, inventors should ask themselves: What is feasible in an academic setting? What is valued more by the investors? Should it be performed in-house or be out-sourced? How much would it cost?
Columbia Technology Ventures (CTV) and venture investors Osage University Partners (OUP) invite you to view a seminar on the following topic: “The behind-the-scenes view on how VCs evaluate potential startup CEOS.”
Drawing from 25 years of venture capital experience, Osage University Partners (OUP) managing partner Marc Singer will take you through the CEO search process, how VCs evaluate potential entrepreneur, and some observations about drivers for long-term success as an entrepreneur. The audience will assess mock candidate profiles and learn methods of diligence to choose the right leader for your startup.
Columbia Technology Ventures (CTV) and venture investors Osage University Partners (OUP) invite you to join a seminar on the following topic: “Understanding the real economics of university startup formation.”
OUP principal John Lee will take you step-by-step through the life of a company, illustrating the different types equity, the pros and cons of each equity type depending on different company outcomes, and the economic effect this has on founders’ shares. Data will be presented to support the conversation around founders’ equity, the right allocation between faculty vs. post docs vs. grad students, and how much equity one needs to give away to attract and keep your top talent.
This workshop will focus on teaching you how to help investigators focus their technology disclosures, funding pitches, and other presentations on the three key factors crucial to gaining interest and commitment: commercial potential, technical merit and investigator willingness to assist.